Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit...

The OncoLens team will be hosting a free CME event Molecular Testing in The Community Oncology Setting: Where We Are And Where We Are Going. During this session, Maria E. Arcila, MD of the Memorial Sloan Kettering Cancer Center, will...